Global Anemia Drugs Market Size, Status and Forecast 2022

October 2017 | 107 pages | ID: G459BC2CE0CPEN
QYResearch

Abstracts

This report studies the global Anemia Drugs market, analyzes and researches the Anemia Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like

• GlaxoSmithKline
• Global Blood Therapeutics (GBT)
• Bluebird Bio
• GlycoMimetics
• Mast Therapeutics
• Fibrogen
• Akebia Therapeutics
• Bayer AG
• Eli Lilly
• Regen Biopharma
• Acceleron Pharma
• Celgene Corporation
• Onconova Therapeutics
• Pieris Pharmaceuticals

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, Anemia Drugs can be split into

• Oral
• Injection

Market segment by Application, Anemia Drugs can be split into

• Iron Deficiency Anemia
• Chronic Kidney Disease related Anemia
• Sickle Cell Anemia
• Aplastic Anemia

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Anemia Drugs Market Size, Status and Forecast 2022

1 INDUSTRY OVERVIEW OF ANEMIA DRUGS

1.1 Anemia Drugs Market Overview
  1.1.1 Anemia Drugs Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Anemia Drugs Market Size and Analysis by Regions
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Anemia Drugs Market by Type
  1.3.1 Oral
  1.3.2 Injection
1.4 Anemia Drugs Market by End Users/Application
  1.4.1 Iron Deficiency Anemia
  1.4.2 Chronic Kidney Disease related Anemia
  1.4.3 Sickle Cell Anemia
  1.4.4 Aplastic Anemia

2 GLOBAL ANEMIA DRUGS COMPETITION ANALYSIS BY PLAYERS

2.1 Anemia Drugs Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 GlaxoSmithKline
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Anemia Drugs Revenue (Value) (2012-2017)
  3.1.5 Recent Developments
3.2 Global Blood Therapeutics (GBT)
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Anemia Drugs Revenue (Value) (2012-2017)
  3.2.5 Recent Developments
3.3 Bluebird Bio
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Anemia Drugs Revenue (Value) (2012-2017)
  3.3.5 Recent Developments
3.4 GlycoMimetics
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Anemia Drugs Revenue (Value) (2012-2017)
  3.4.5 Recent Developments
3.5 Mast Therapeutics
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Anemia Drugs Revenue (Value) (2012-2017)
  3.5.5 Recent Developments
3.6 Fibrogen
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Anemia Drugs Revenue (Value) (2012-2017)
  3.6.5 Recent Developments
3.7 Akebia Therapeutics
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Anemia Drugs Revenue (Value) (2012-2017)
  3.7.5 Recent Developments
3.8 Bayer AG
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Anemia Drugs Revenue (Value) (2012-2017)
  3.8.5 Recent Developments
3.9 Eli Lilly
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Anemia Drugs Revenue (Value) (2012-2017)
  3.9.5 Recent Developments
3.10 Regen Biopharma
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 Anemia Drugs Revenue (Value) (2012-2017)
  3.10.5 Recent Developments
3.11 Acceleron Pharma
3.12 Celgene Corporation
3.13 Onconova Therapeutics
3.14 Pieris Pharmaceuticals

4 GLOBAL ANEMIA DRUGS MARKET SIZE BY TYPE AND APPLICATION (2012-2017)

4.1 Global Anemia Drugs Market Size by Type (2012-2017)
4.2 Global Anemia Drugs Market Size by Application (2012-2017)
4.3 Potential Application of Anemia Drugs in Future
4.4 Top Consumer/End Users of Anemia Drugs

5 UNITED STATES ANEMIA DRUGS DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Anemia Drugs Market Size (2012-2017)
5.2 United States Anemia Drugs Market Size and Market Share by Players (2016 and 2017)

6 EU ANEMIA DRUGS DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Anemia Drugs Market Size (2012-2017)
6.2 EU Anemia Drugs Market Size and Market Share by Players (2016 and 2017)

7 JAPAN ANEMIA DRUGS DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Anemia Drugs Market Size (2012-2017)
7.2 Japan Anemia Drugs Market Size and Market Share by Players (2016 and 2017)

8 CHINA ANEMIA DRUGS DEVELOPMENT STATUS AND OUTLOOK

8.1 China Anemia Drugs Market Size (2012-2017)
8.2 China Anemia Drugs Market Size and Market Share by Players (2016 and 2017)

9 INDIA ANEMIA DRUGS DEVELOPMENT STATUS AND OUTLOOK

9.1 India Anemia Drugs Market Size (2012-2017)
9.2 India Anemia Drugs Market Size and Market Share by Players (2016 and 2017)

10 SOUTHEAST ASIA ANEMIA DRUGS DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Anemia Drugs Market Size (2012-2017)
10.2 Southeast Asia Anemia Drugs Market Size and Market Share by Players (2016 and 2017)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)

11.1 Global Anemia Drugs Market Size (Value) by Regions (2017-2022)
  11.1.1 United States Anemia Drugs Revenue and Growth Rate (2017-2022)
  11.1.2 EU Anemia Drugs Revenue and Growth Rate (2017-2022)
  11.1.3 Japan Anemia Drugs Revenue and Growth Rate (2017-2022)
  11.1.4 China Anemia Drugs Revenue and Growth Rate (2017-2022)
  11.1.5 India Anemia Drugs Revenue and Growth Rate (2017-2022)
  11.1.6 Southeast Asia Anemia Drugs Revenue and Growth Rate (2017-2022)
11.2 Global Anemia Drugs Market Size (Value) by Type (2017-2022)
11.3 Global Anemia Drugs Market Size by Application (2017-2022)

12 ANEMIA DRUGS MARKET DYNAMICS

12.1 Anemia Drugs Market Opportunities
12.2 Anemia Drugs Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Anemia Drugs Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Anemia Drugs Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Anemia Drugs Product Scope
Figure Global Anemia Drugs Market Size (Million USD) (2012-2017)
Table Global Anemia Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Anemia Drugs Market Share by Regions in 2016
Figure United States Anemia Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Anemia Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Anemia Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Anemia Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Anemia Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Anemia Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Anemia Drugs Market Share by Type in 2016
Figure Oral Market Size (Million USD) and Growth Rate (2012-2017)
Figure Injection Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Anemia Drugs Market Share by Application in 2016
Table Key Downstream Customer in Iron Deficiency Anemia
Figure Anemia Drugs Market Size (Million USD) and Growth Rate in Iron Deficiency Anemia (2012-2017)
Table Key Downstream Customer in Chronic Kidney Disease related Anemia
Figure Anemia Drugs Market Size (Million USD) and Growth Rate in Chronic Kidney Disease related Anemia (2012-2017)
Table Key Downstream Customer in Sickle Cell Anemia
Figure Anemia Drugs Market Size (Million USD) and Growth Rate in Sickle Cell Anemia (2012-2017)
Table Key Downstream Customer in Aplastic Anemia
Figure Anemia Drugs Market Size (Million USD) and Growth Rate in Aplastic Anemia (2012-2017)
Table Anemia Drugs Market Size (Million USD) by Players (2016 and 2017)
Figure Anemia Drugs Market Size Share by Players in 2016
Figure Anemia Drugs Market Size Share by Players in 2017
Table GlaxoSmithKline Basic Information List
Table Anemia Drugs Business Revenue (Million USD) of GlaxoSmithKline (2012-2017)
Figure GlaxoSmithKline Anemia Drugs Business Revenue Market Share in 2016
Table Global Blood Therapeutics (GBT) Basic Information List
Table Anemia Drugs Business Revenue (Million USD) of Global Blood Therapeutics (GBT) (2012-2017)
Figure Global Blood Therapeutics (GBT) Anemia Drugs Business Revenue Market Share in 2016
Table Bluebird Bio Basic Information List
Table Anemia Drugs Business Revenue (Million USD) of Bluebird Bio (2012-2017)
Figure Bluebird Bio Anemia Drugs Business Revenue Market Share in 2016
Table GlycoMimetics Basic Information List
Table Anemia Drugs Business Revenue (Million USD) of GlycoMimetics (2012-2017)
Figure GlycoMimetics Anemia Drugs Business Revenue Market Share in 2016
Table Mast Therapeutics Basic Information List
Table Anemia Drugs Business Revenue (Million USD) of Mast Therapeutics (2012-2017)
Figure Mast Therapeutics Anemia Drugs Business Revenue Market Share in 2016
Table Fibrogen Basic Information List
Table Anemia Drugs Business Revenue (Million USD) of Fibrogen (2012-2017)
Figure Fibrogen Anemia Drugs Business Revenue Market Share in 2016
Table Akebia Therapeutics Basic Information List
Table Anemia Drugs Business Revenue (Million USD) of Akebia Therapeutics (2012-2017)
Figure Akebia Therapeutics Anemia Drugs Business Revenue Market Share in 2016
Table Bayer AG Basic Information List
Table Anemia Drugs Business Revenue (Million USD) of Bayer AG (2012-2017)
Figure Bayer AG Anemia Drugs Business Revenue Market Share in 2016
Table Eli Lilly Basic Information List
Table Anemia Drugs Business Revenue (Million USD) of Eli Lilly (2012-2017)
Figure Eli Lilly Anemia Drugs Business Revenue Market Share in 2016
Table Regen Biopharma Basic Information List
Table Anemia Drugs Business Revenue (Million USD) of Regen Biopharma (2012-2017)
Figure Regen Biopharma Anemia Drugs Business Revenue Market Share in 2016
Table Acceleron Pharma Basic Information List
Table Anemia Drugs Business Revenue (Million USD) of Acceleron Pharma (2012-2017)
Figure Acceleron Pharma Anemia Drugs Business Revenue Market Share in 2016
Table Celgene Corporation Basic Information List
Table Anemia Drugs Business Revenue (Million USD) of Celgene Corporation (2012-2017)
Figure Celgene Corporation Anemia Drugs Business Revenue Market Share in 2016
Table Onconova Therapeutics Basic Information List
Table Anemia Drugs Business Revenue (Million USD) of Onconova Therapeutics (2012-2017)
Figure Onconova Therapeutics Anemia Drugs Business Revenue Market Share in 2016
Table Pieris Pharmaceuticals Basic Information List
Table Anemia Drugs Business Revenue (Million USD) of Pieris Pharmaceuticals (2012-2017)
Figure Pieris Pharmaceuticals Anemia Drugs Business Revenue Market Share in 2016
Table Global Anemia Drugs Market Size (Million USD) by Type (2012-2017)
Figure Global Anemia Drugs Market Size Share by Type in 2012
Figure Global Anemia Drugs Market Size Share by Type in 2013
Figure Global Anemia Drugs Market Size Share by Type in 2014
Figure Global Anemia Drugs Market Size Share by Type in 2015
Figure Global Anemia Drugs Market Size Share by Type in 2016
Figure Global Anemia Drugs Market Size Share by Type in 2017
Table Global Anemia Drugs Market Size (Million USD) by Application (2012-2017)
Figure Global Anemia Drugs Market Size (Million USD) by Application in 2012
Figure Global Anemia Drugs Market Size (Million USD) by Application in 2013
Figure Global Anemia Drugs Market Size (Million USD) by Application in 2014
Figure Global Anemia Drugs Market Size (Million USD) by Application in 2015
Figure Global Anemia Drugs Market Size (Million USD) by Application in 2016
Figure Global Anemia Drugs Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Anemia Drugs
Figure United States Anemia Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Anemia Drugs Market Size (Million USD) by Players (2012-2017)
Figure United States Anemia Drugs Market Size Share by Players in 2016
Figure United States Anemia Drugs Market Size Share by Players in 2017
Figure EU Anemia Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Anemia Drugs Market Size (Million USD) by Players (2012-2017)
Figure EU Anemia Drugs Market Size Share by Players in 2016
Figure EU Anemia Drugs Market Size Share by Players in 2017
Figure Japan Anemia Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Anemia Drugs Market Size (Million USD) by Players (2012-2017)
Figure Japan Anemia Drugs Market Size Share by Players in 2016
Figure Japan Anemia Drugs Market Size Share by Players in 2017
Figure China Anemia Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Anemia Drugs Market Size (Million USD) by Players (2012-2017)
Figure China Anemia Drugs Market Size Share by Players in 2016
Figure China Anemia Drugs Market Size Share by Players in 2017
Figure India Anemia Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Anemia Drugs Market Size (Million USD) by Players (2012-2017)
Figure India Anemia Drugs Market Size Share by Players in 2016
Figure India Anemia Drugs Market Size Share by Players in 2017
Figure Southeast Asia Anemia Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Anemia Drugs Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Anemia Drugs Market Size Share by Players in 2016
Figure Southeast Asia Anemia Drugs Market Size Share by Players in 2017
Figure Global Anemia Drugs Market Size (Million USD) by Regions (2017-2022)
Table Global Anemia Drugs Market Size (Million USD) by Regions (2017-2022)
Figure Global Anemia Drugs Market Size Share by Regions in 2017
Figure Global Anemia Drugs Market Size Share by Regions in 2022
Figure United States Anemia Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Anemia Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Anemia Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Anemia Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Anemia Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Anemia Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Anemia Drugs Market Size (Million USD) by Type (2017-2022)
Figure Global Anemia Drugs Market Size Share by Type in 2017
Figure Global Anemia Drugs Market Size Share by Type in 2022
Table Global Anemia Drugs Market Size (Million USD) by Application (2017-2022)
Figure Global Anemia Drugs Market Size (Million USD) by Application in 2017
Figure Global Anemia Drugs Market Size (Million USD) by Application in 2022